• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克鲁蛋白酶的拟肽乙烯基杂环抑制剂具有抗锥虫活性。

Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.

作者信息

Chenna Bala C, Li Linfeng, Mellott Drake M, Zhai Xiang, Siqueira-Neto Jair L, Calvet Alvarez Claudia, Bernatchez Jean A, Desormeaux Emily, Alvarez Hernandez Elizabeth, Gomez Jana, McKerrow James H, Cruz-Reyes Jorge, Meek Thomas D

机构信息

Department of Biochemistry & Biophysics, Texas A&M University, 301 Old Main Drive, College Station, Texas 77843, United States.

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.

出版信息

J Med Chem. 2020 Mar 26;63(6):3298-3316. doi: 10.1021/acs.jmedchem.9b02078. Epub 2020 Mar 17.

DOI:10.1021/acs.jmedchem.9b02078
PMID:32125159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7261474/
Abstract

Cruzain, an essential cysteine protease of the parasitic protozoan, , is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive "warheads" of vinyl sulfone inactivators of cruzain. Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) containing Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (* = 0.1-0.4 μM). These cruzain inhibitors exhibited moderate to excellent selectivity versus human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of (EC = 1-15 μM) and eliminated in infected murine cardiomyoblasts (EC = 5-8 μM). PVHIs represent a new class of cruzain inhibitors that could progress to viable candidate compounds to treat Chagas disease and human sleeping sickness.

摘要

克鲁兹蛋白酶是寄生原生动物的一种必需半胱氨酸蛋白酶,是恰加斯病的重要药物靶点。我们在此描述了一系列新的可逆但具有时间依赖性的克鲁兹蛋白酶抑制剂,它们由连接到乙烯基杂环上的二肽支架组成,旨在替代克鲁兹蛋白酶乙烯砜失活剂中不可逆的反应性“弹头”。含有Cbz-Phe-Phe/高苯丙氨酸支架以及乙烯基-2-嘧啶、乙烯基-2-吡啶和乙烯基-2-(-甲基)-吡啶基团的拟肽乙烯基杂环抑制剂(PVHIs)对克鲁兹蛋白酶具有可逆的、时间依赖性抑制作用(* = 0.1 - 0.4 μM)。这些克鲁兹蛋白酶抑制剂对人组织蛋白酶B、L和S表现出中度至优异的选择性,对人细胞无明显毒性,但在锥虫细胞培养中有效(EC = 1 - 15 μM),并在感染的小鼠心肌成纤维细胞中清除锥虫(EC = 5 - 8 μM)。PVHIs代表了一类新的克鲁兹蛋白酶抑制剂,有望发展成为治疗恰加斯病和人类昏睡病的可行候选化合物。

相似文献

1
Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.克鲁蛋白酶的拟肽乙烯基杂环抑制剂具有抗锥虫活性。
J Med Chem. 2020 Mar 26;63(6):3298-3316. doi: 10.1021/acs.jmedchem.9b02078. Epub 2020 Mar 17.
2
Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies.氟乙烯基砜和砜酸盐作为有效的半胱氨酸蛋白酶可逆共价抑制剂在锥虫中的应用:结构-活性关系、抑制机制、代谢和体内研究。
J Med Chem. 2021 Aug 26;64(16):12322-12358. doi: 10.1021/acs.jmedchem.1c01002. Epub 2021 Aug 11.
3
In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.体外和体内研究 WRR-483 对克氏锥虫的杀锥虫作用。
PLoS Negl Trop Dis. 2010 Sep 14;4(9):e825. doi: 10.1371/journal.pntd.0000825.
4
Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.锥虫半胱氨酸蛋白酶克氏锥虫蛋白酶的强效第二代乙烯基磺酰胺抑制剂。
Bioorg Med Chem Lett. 2001 Oct 22;11(20):2759-62. doi: 10.1016/s0960-894x(01)00566-2.
5
Synthesis of macrocyclic trypanosomal cysteine protease inhibitors.大环锥虫半胱氨酸蛋白酶抑制剂的合成。
Bioorg Med Chem Lett. 2008 Nov 15;18(22):5860-3. doi: 10.1016/j.bmcl.2008.06.012. Epub 2008 Jun 10.
6
Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.基于结构的构象受限半胱氨酸蛋白酶抑制剂的设计、合成与评价
Bioorg Med Chem. 1998 Dec;6(12):2477-94. doi: 10.1016/s0968-0896(98)80022-9.
7
Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.设计、合成及生物评价强效瑞香烷肽腈类抑制剂及基于活性的探针作为有前景的抗布氏锥虫药物。
Chemistry. 2012 May 21;18(21):6528-41. doi: 10.1002/chem.201103322. Epub 2012 Apr 4.
8
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.鉴定和优化克氏锥虫半胱氨酸蛋白酶抑制剂:克氏锥虫 cruzain、rhodesain 和 TbCatB。
J Med Chem. 2010 Jan 14;53(1):52-60. doi: 10.1021/jm901069a.
9
Aryl ureas represent a new class of anti-trypanosomal agents.芳基脲类是一类新型抗锥虫剂。
Chem Biol. 2000 Sep;7(9):733-42. doi: 10.1016/s1074-5521(00)00018-1.
10
Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.一系列作为克鲁兹蛋白酶抑制剂的苯并咪唑衍生物的分子建模与构效关系
Future Med Chem. 2017 May;9(7):641-657. doi: 10.4155/fmc-2016-0236. Epub 2017 May 16.

引用本文的文献

1
Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (, ) and Their Azole Derivatives against Chagas Disease.合成与新的含硫半卡巴腙( , )及其唑类衍生物的生物评价对恰加斯病。
J Med Chem. 2024 Nov 14;67(21):19038-19056. doi: 10.1021/acs.jmedchem.4c01535. Epub 2024 Nov 1.
2
Integrated Computational Approaches for Drug Design Targeting Cruzipain.靶向 cruzipain 的药物设计的综合计算方法。
Int J Mol Sci. 2024 Mar 27;25(7):3747. doi: 10.3390/ijms25073747.
3
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of .

本文引用的文献

1
Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and Cruzain.半胱氨酸蛋白酶人组织蛋白酶 L 和克氏锥虫 cruzain 的强效抑制剂类半胱天冬酶抑制剂的设计。
J Med Chem. 2019 Oct 24;62(20):9026-9044. doi: 10.1021/acs.jmedchem.9b00294. Epub 2019 Oct 4.
2
Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?半胱氨酸蛋白酶跨类抑制剂可以实现选择性吗?
J Med Chem. 2019 Dec 12;62(23):10497-10525. doi: 10.1021/acs.jmedchem.9b00683. Epub 2019 Aug 15.
3
Update on drug development targeting parasite cysteine proteases.
新型克氏锥虫半胱氨酸蛋白酶抑制剂的发现
Curr Med Chem. 2024;31(16):2285-2308. doi: 10.2174/0109298673254864230921090519.
4
Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options.用于被忽视疾病的共价抑制剂:新型治疗选择的探索
Pharmaceuticals (Basel). 2023 Jul 19;16(7):1028. doi: 10.3390/ph16071028.
5
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study.弹头与蛋白酶抑制剂的拟肽序列的相容性研究-全面的反应性和选择性研究。
Int J Mol Sci. 2023 Apr 13;24(8):7226. doi: 10.3390/ijms24087226.
6
Identification of Leucinostatins from sp. as Antiparasitic Agents against .从……中鉴定出亮抑素作为抗……的抗寄生虫剂。 (注:原文中“sp.”和“.”处信息缺失,以上是按格式要求给出的尽量完整译文)
ACS Omega. 2022 Jan 28;7(9):7675-7682. doi: 10.1021/acsomega.1c06347. eCollection 2022 Mar 8.
7
Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases.自掩蔽醛抑制剂:抑制半胱氨酸蛋白酶的新策略。
J Med Chem. 2021 Aug 12;64(15):11267-11287. doi: 10.1021/acs.jmedchem.1c00628. Epub 2021 Jul 21.
8
Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors.作为克氏锥虫抑制剂的一系列咪唑类化合物的 chemoinformatics 研究。
Biomolecules. 2021 Apr 15;11(4):579. doi: 10.3390/biom11040579.
9
Predictive Global Models of Cruzain Inhibitors with Large Chemical Coverage.具有广泛化学覆盖范围的克鲁兹蛋白酶抑制剂预测性全局模型。
ACS Omega. 2021 Mar 5;6(10):6722-6735. doi: 10.1021/acsomega.0c05645. eCollection 2021 Mar 16.
靶向寄生虫半胱氨酸蛋白酶的药物研发进展
PLoS Negl Trop Dis. 2018 Aug 23;12(8):e0005850. doi: 10.1371/journal.pntd.0005850. eCollection 2018 Aug.
4
Progress with covalent small-molecule kinase inhibitors.共价小分子激酶抑制剂的研究进展。
Drug Discov Today. 2018 Mar;23(3):727-735. doi: 10.1016/j.drudis.2018.01.035. Epub 2018 Jan 11.
5
Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics.从稳态和预稳态动力学的溶剂动力学同位素效应确定的克氏锥虫克鲁斯蛋白酶的催化机制
Biochemistry. 2018 Jun 5;57(22):3176-3190. doi: 10.1021/acs.biochem.7b01250. Epub 2018 Feb 2.
6
Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660).在一项口服组织蛋白酶C抑制剂(GSK2793660)的I期研究中观察到上皮脱屑。
Br J Clin Pharmacol. 2017 Dec;83(12):2813-2820. doi: 10.1111/bcp.13398. Epub 2017 Sep 20.
7
Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned.组织蛋白酶 K 抑制剂治疗骨质疏松症:生物学、潜在临床应用及经验教训。
Endocr Rev. 2017 Aug 1;38(4):325-350. doi: 10.1210/er.2015-1114.
8
What Do We Know About Chagas Disease in the United States?我们对美国的恰加斯病了解多少?
Am J Trop Med Hyg. 2016 Dec 7;95(6):1225-1227. doi: 10.4269/ajtmh.16-0213. Epub 2016 Jul 11.
9
Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain.半胱氨酸蛋白酶抑制剂WRR-483的氧胍类似物对克鲁兹蛋白酶的合成与评价
ACS Med Chem Lett. 2015 Dec 15;7(1):77-82. doi: 10.1021/acsmedchemlett.5b00336. eCollection 2016 Jan 14.
10
Cathepsin L targeting in cancer treatment.癌症治疗中的组织蛋白酶L靶向作用。
Pharmacol Ther. 2015 Nov;155:105-16. doi: 10.1016/j.pharmthera.2015.08.007. Epub 2015 Aug 20.